CClinicalTrials.gg
Status unknownNCT01217593Updated Mar 21, 2014

Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast Surgery

An interventional study of ultrasound and predetermined distance in Mastectomy and Breast Neoplasms, sponsored by Ochsner Health System. Status unknown at 1 site in United States. Open to female participants aged 25 Years to 85 Years. Per ClinicalTrials.gov, last updated 2014-03-21.

Sponsored by Ochsner Health System · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Mar 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 85 Years
Sex
Female
01

Study summary

The purpose of this study is to compare ultrasound and predetermined distance techniques for finding the paravertebral space to inject the local anesthetic (numbing medicine) when you are given anesthesia for surgery. The paravertebral space is located on either side of the spinal cord and contains the nerves that provide sensation to the chest wall. The predetermined distance technique is a series of measurements taken to determine the location of the paravertebral space where the local anesthetic is injected. The ultrasound technique uses direct visualization of the local anesthetic being placed in the paravertebral space. This type of anesthesia has many benefits including decreasing your pain after breast surgery.

02

Conditions studied

  • Mastectomy
  • Breast Neoplasms

Browse trials for

Keywords

  • mastectomy
  • breast cancer
  • breast surgery
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 60 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Ochsner Health System is the lead sponsor of 54 studies on the registry; 7 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 85 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Females age 25 - 85
  • ASA Physical status I-III
  • Scheduled for primary mastectomy
  • Ability to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Allergy to:

Local anesthetics Fentanyl Hydromorphone Propofol Midazolam

  • Patient refusal
  • Infection at the injection site
  • Peripheral Neuropathy
  • Bilateral breast surgery
  • Prior thoracic surgery on surgical side
  • Severe spinal deformity
  • Coagulopathy
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    ultrasound

    Ultrasound guidance will be used for paravertebral space localization when performing paravertebral blocks on females 25-85 having unilateral mastectomy.

    Procedure: ultrasound

  • Active comparator
    predetermined distance

    The predetermined distance technique will be used for paravertebral space localization when performing paravertebral blocks on females 25-85 having unilateral mastectomy.

    Procedure: predetermined distance

Interventions

  • Procedureultrasound

    Ultrasound guidance will be used for paravertebral space localization when performing paravertebral blocks on females 25-85 having unilateral mastectomy.

  • Procedurepredetermined distance

    The predetermined distance technique will be used for paravertebral space localization when performing paravertebral blocks on females 25-85 having unilateral mastectomy.

06

What researchers measure

Primary outcomes

  1. Visual analog scores(VAS)for pain and perioperative opioid requirements

    The VAS scores and the opioid consumption will be compared between the ultrasound group and the predetermined distance technique group.

    Time frame: 24 hours

Secondary outcomes

  1. time, incidence of adverse events and patient satisfaction

    The secondary objectives will be 1) time taken to locate the paravertebral space and inject local anesthetic 2) time from injection of local anesthetic to adequate sensory block 3) incidence of adverse events including pneumothorax, high spinal, epidural spread, direct nerve damage, paresthesias, vascular puncture, patient discomfort, respiratory depression, hypoxemia, and prolonged sensory blockade and 4) patient satisfaction.

    Time frame: 24 hours

07

Study locations

1 of 1 sites recruiting
  • Ochsner Clinic Foundation
    New Orleans, Louisiana 70121, United States
    Recruiting
08

References and documents

Publications

  • la Grange P, Foster PA, Pretorius LK. Application of the Doppler ultrasound bloodflow detector in supraclavicular brachial plexus block. Br J Anaesth. 1978 Sep;50(9):965-7. doi: 10.1093/bja/50.9.965. PubMed 708565 ↗
  • Marhofer P, Schrogendorfer K, Koinig H, Kapral S, Weinstabl C, Mayer N. Ultrasonographic guidance improves sensory block and onset time of three-in-one blocks. Anesth Analg. 1997 Oct;85(4):854-7. doi: 10.1097/00000539-199710000-00026. PubMed 9322469 ↗
  • Domingo-Triado V, Selfa S, Martinez F, Sanchez-Contreras D, Reche M, Tecles J, Crespo MT, Palanca JM, Moro B. Ultrasound guidance for lateral midfemoral sciatic nerve block: a prospective, comparative, randomized study. Anesth Analg. 2007 May;104(5):1270-4, tables of contents. doi: 10.1213/01.ane.0000221469.24319.49. PubMed 17456685 ↗
  • Willschke H, Marhofer P, Bosenberg A, Johnston S, Wanzel O, Cox SG, Sitzwohl C, Kapral S. Ultrasonography for ilioinguinal/iliohypogastric nerve blocks in children. Br J Anaesth. 2005 Aug;95(2):226-30. doi: 10.1093/bja/aei157. Epub 2005 May 27. PubMed 15923270 ↗
  • Oberndorfer U, Marhofer P, Bosenberg A, Willschke H, Felfernig M, Weintraud M, Kapral S, Kettner SC. Ultrasonographic guidance for sciatic and femoral nerve blocks in children. Br J Anaesth. 2007 Jun;98(6):797-801. doi: 10.1093/bja/aem092. Epub 2007 Apr 21. PubMed 17449890 ↗
  • Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth. 2009 Nov;103(5):685-90. doi: 10.1093/bja/aep261. Epub 2009 Sep 22. Erratum In: Br J Anaesth. 2010 Apr;104(4):516. PubMed 19776028 ↗
  • Boughey JC, Goravanchi F, Parris RN, Kee SS, Kowalski AM, Frenzel JC, Bedrosian I, Meric-Bernstam F, Hunt KK, Ames FC, Kuerer HM, Lucci A. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg. 2009 Nov;198(5):720-5. doi: 10.1016/j.amjsurg.2008.11.043. Epub 2009 May 9. PubMed 19427625 ↗
  • Goldfarb Y, Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis. 2006-2007;26:99-114. doi: 10.3233/bd-2007-26109. PubMed 17473369 ↗
  • Coveney E, Weltz CR, Greengrass R, Iglehart JD, Leight GS, Steele SM, Lyerly HK. Use of paravertebral block anesthesia in the surgical management of breast cancer: experience in 156 cases. Ann Surg. 1998 Apr;227(4):496-501. doi: 10.1097/00000658-199804000-00008. PubMed 9563536 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01217593
Lead sponsor
Ochsner Health System
Responsible party
Kristie Osteen (Director of Perioperative Anesthesia, Ochsner Health System) — Principal investigator
First posted
Oct 8, 2010
Start date
Oct 2010
Primary completion
Oct 2016 (estimated)
Completion
Oct 2016 (estimated)
Last update
Mar 21, 2014

Study contacts

Kristie Osteen, MD
Contact
kosteen@ochsner.org
504-842-3755
Heather S Porter, BA
Contact
hporter@ochsner.org
504-842-4812
Kristie Osteen, MD
principal investigator · Ochsner Health System

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion